Related references
Note: Only part of the references are listed.Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation
Yanan Cao et al.
JOURNAL OF HEPATOLOGY (2013)
Current Understanding of the Molecular Biology of Pancreatic Neuroendocrine Tumors
Jianliang Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
Luc G. T. Morris et al.
NATURE GENETICS (2013)
18F-Radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals
Haifei Wu et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Xiaomo Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Menin: a scaffold protein that controls gene expression and cell signaling
Smita Matkar et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
The same pocket in menin binds both MLL and JUND but has opposite effects on transcription
Jing Huang et al.
NATURE (2012)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance
Tobias Sinnberg et al.
PLOS ONE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
β-Catenin regulates airway smooth muscle contraction
Sepp R. Jansen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
MLL-AF9-Induced Leukemogenesis Requires Coexpression of the Wild-Type Mll Allele
Austin T. Thiel et al.
CANCER CELL (2010)
Regulation of Cyclin B2 Expression and Cell Cycle G2/M Transition by Menin
Ting Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene
Yuqing Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo
Rajesh Kumar Gandhirajan et al.
NEOPLASIA (2010)
Lack of β-catenin in early life induces abnormal glucose homeostasis in mice
S. Dabernat et al.
DIABETOLOGIA (2009)
Nuclear-Cytoplasmic Shuttling of Menin Regulates Nuclear Translocation of β-Catenin
Yanan Cao et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes
Merav Fraenkel et al.
DIABETES (2008)
The T cell factor/β-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells
Mabrouka Doghman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Population-based study of islet cell carcinoma
James C. Yao et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1
Xiao-Hua Jiang et al.
ENDOCRINE-RELATED CANCER (2007)
Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Kumar Sukhdeo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Wnt signaling regulates pancreatic β cell proliferation
Ingrid C. Rulifson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gene expression profiling in insulinomas of Men1 β-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic β-cell tumorigenesis
S. Fontaniere et al.
ENDOCRINE-RELATED CANCER (2006)
Stabilization of β-catenin impacts pancreas growth
PW Heiser et al.
DEVELOPMENT (2006)
β-Catenin is essential for pancreatic acinar but not islet development
LC Murtaugh et al.
DEVELOPMENT (2005)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
Pancreas-specific deletion of β-catenin reveals Wnt-dependent and Wnt-independent functions during development
J Dessimoz et al.
CURRENT BIOLOGY (2005)
Convergence of Wnt, β-catenin, and cadherin pathways
WJ Nelson et al.
SCIENCE (2004)
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
M Lepourcelet et al.
CANCER CELL (2004)
Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway
S Amit et al.
GENES & DEVELOPMENT (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Share Paper
